STOP-HF is a double-blinded, placebo-controlled, multi-center trial of its non-viral DNA plasmid therapy JVS-100 for patients with symptomatic heart failure.
http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Juventas-Therapeutics-completes-enrollment-of-Phas/ArticleNewsFeed/Article/detail/826753?ref=25
http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Juventas-Therapeutics-completes-enrollment-of-Phas/ArticleNewsFeed/Article/detail/826753?ref=25
No comments:
Post a Comment